Zhejiang Gongdong Medical Technology Co Ltd (605369) - Total Assets
Based on the latest financial reports, Zhejiang Gongdong Medical Technology Co Ltd (605369) holds total assets worth CN¥2.19 Billion CNY (≈ $319.97 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhejiang Gongdong Medical Technology Co Ltd - Total Assets Trend (2016–2025)
This chart illustrates how Zhejiang Gongdong Medical Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Zhejiang Gongdong Medical Technology Co stock valuation for the company's overall valuation and market capitalisation.
Zhejiang Gongdong Medical Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Zhejiang Gongdong Medical Technology Co Ltd's total assets of CN¥2.19 Billion consist of 50.9% current assets and 49.1% non-current assets. Review Zhejiang Gongdong Medical Technology Co total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 25.1% |
| Accounts Receivable | CN¥278.28 Million | 13.1% |
| Inventory | CN¥138.13 Million | 6.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥146.71 Million | 6.9% |
| Goodwill | CN¥172.70 Million | 8.2% |
Asset Composition Trend (2016–2025)
This chart illustrates how Zhejiang Gongdong Medical Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Zhejiang Gongdong Medical Technology Co for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Gongdong Medical Technology Co Ltd's current assets represent 50.9% of total assets in 2025, a decrease from 67.8% in 2016.
- Cash Position: Cash and equivalents constituted 25.1% of total assets in 2025, up from 18.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 11.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 13.1% of total assets.
Zhejiang Gongdong Medical Technology Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Gongdong Medical Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Zhejiang Gongdong Medical Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.73 | 4.17 | 5.51 |
| Quick Ratio | 2.45 | 3.59 | 4.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥727.37 Million | CN¥752.85 Million | CN¥832.34 Million |
Zhejiang Gongdong Medical Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Gongdong Medical Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.89 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | 8.6% |
| Total Assets | CN¥2.12 Billion |
| Market Capitalization | $536.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Gongdong Medical Technology Co Ltd's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhejiang Gongdong Medical Technology Co Ltd's assets grew by 8.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhejiang Gongdong Medical Technology Co Ltd (2016–2025)
The table below shows the annual total assets of Zhejiang Gongdong Medical Technology Co Ltd from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.12 Billion ≈ $310.04 Million |
+8.58% |
| 2024-12-31 | CN¥1.95 Billion ≈ $285.54 Million |
+3.92% |
| 2023-12-31 | CN¥1.88 Billion ≈ $274.76 Million |
+0.55% |
| 2022-12-31 | CN¥1.87 Billion ≈ $273.27 Million |
+10.51% |
| 2021-12-31 | CN¥1.69 Billion ≈ $247.29 Million |
+22.84% |
| 2020-12-31 | CN¥1.38 Billion ≈ $201.30 Million |
+156.64% |
| 2019-12-31 | CN¥536.04 Million ≈ $78.44 Million |
+15.44% |
| 2018-12-31 | CN¥464.35 Million ≈ $67.95 Million |
+41.27% |
| 2017-12-31 | CN¥328.69 Million ≈ $48.10 Million |
-6.61% |
| 2016-12-31 | CN¥351.98 Million ≈ $51.51 Million |
-- |
About Zhejiang Gongdong Medical Technology Co Ltd
Zhejiang Gongdong Medical Technology Co., Ltd. researches, develops, produces, and sells disposable medical consumables in China. Its products include blood collection tubes, needles and needle holders, and sharp containers; cell culture dishes, plates, bottles, flasks, and serological pipette solutions; laboratory consumables, such as petri dishes, centrifuge and cryo tubes, pipette tips, transf… Read more